Best Hearing and Vision Grants in New Hampshire

The Joe and Janet Barr Early Career Cornea and Contact Lens Research Award supports first- or second-year MS or PhD students in vision science or physiological optics. Established in 2012 in honor of Joseph T. Barr, this $2,000 seed funding facilitates research in cornea/ocular surface or contact lenses. Recipients are required to attend the annual American Academy of Optometry meeting and submit progress reports detailing their research outcomes. Preference is given to North American applicants.

The Reeves Foundation supports research aimed at understanding and treating macular degeneration, a condition that has personally affected the founder's family. Established in 1997, the foundation allocates 50% of its grants to research and the other half to local charities in Columbus, Indiana. Nonprofit organizations exempt under IRS code 501(c)(3) are eligible to apply, but funds cannot be used for administrative costs. The foundation prioritizes equipment purchases and partnerships with other funding sources.

The Alcon Foundation Grant aims to enhance eye care services and improve patient access, with a focus on educational and training programs. The foundation also supports cultural and community development initiatives that uplift the quality of life in areas where Alcon operates, including cities like Fort Worth, Houston, and Irvine. However, it does not fund non-501(c)(3) organizations, athletic leagues, or fundraising events, among other exclusions.

The Marian and Wayne Sinsel Scholarship, established by Marian Sinsel to honor her late husband Wayne, provides financial support to hearing impaired residents of Appalachian Ohio or Fairfield County. This scholarship aims to assist candidates who are 22 years or younger and plan to pursue education at a post-secondary institution in the U.S. with a minimum award of $1,000, ensuring it does not displace existing state or federal funding.

The National Glaucoma Research Program, funded by BrightFocus Foundation, aims to support groundbreaking research in glaucoma. Established in 1978, the program has awarded over $35 million to 32 projects focusing on understanding and treating this disease. The Standard Awards provide $150,000 over two years for researchers with preliminary data to further their work. Eligible institutions must be non-profit and demonstrate their tax-exempt status to receive funding, fostering innovative solutions for glaucoma treatment.

About Us

Who We Are

The National Federation of the Blind is the oldest and largest nationwide organization of blind Americans. Founded in 1940 and currently headquartered in Baltimore, the NFB consists of affiliates, chapters, and divisions in all fifty states, Washington, DC, and Puerto Rico.

What We Do

Through our network of blind members, we coordinate many programs, services, and resources to defend the rights of blind Americans, provide information and support to blind children and adults, and build a community that creates a future full of opportunities.

What We Believe

We are the only organization that believes in the full capacity of blind people and has the power to transform our dreams into reality. We believe in blind people because we are blind people—from our democratically elected leaders to our diverse nationwide membership.

Scholarship Program

Thanks to our generous partners, there are thirty $10,000 merit-based scholarships currently available. All scholarships are awarded on the basis of academic excellence, community service, and leadership. The finalists are announced every spring. They then attend our national convention in July when the winners of each individual scholarship are selected. 

The American Action Fund for Blind Children and Adults Scholarship

For more than 100 years the American Action Fund for Blind Children and Adults has strived to improve the lives of blind and Deafblind children and adults. Best known for annually producing and gifting Braille Calendars, sponsoring the free Braille books for blind children program, and administering the Braille Readers are Leaders contest, the American Action Fund leads in promoting Braille literacy. The American Action Fund is proud to award this scholarship to a deserving and talented blind person. 

The FY26 Vision Research Program's Investigator-Initiated Research Award (IIRA) offers funding for innovative research addressing eye injury and visual dysfunction due to military exposure. This award supports preclinical to early translational studies aligned with specific focus areas. Unique features include two funding levels and a Partnering Principal Investigator Option. Applications undergo rigorous peer review based on research rationale, strategy, and impact, with potential for sharing with the National Eye Institute for additional funding consideration.

The FY26 Vision Research Program Clinical Trial Award supports the swift execution of clinical trials aimed at improving treatments for service-connected eye injuries and visual dysfunction. This award emphasizes the need for regulatory compliance, including IND/IDE submissions, and requires documentation confirming the application's active status by March 1, 2027. Review criteria focus on clinical impact, research feasibility, recruitment strategies, and ethical considerations, ensuring relevance to military health.

The DoW Vision Research Program's FY26 Translational Research Award aims to accelerate the development of innovative drugs, devices, or clinical guidelines ready for clinical trials. It supports preclinical studies and pilot trials, ensuring alignment with specified VRP Focus Areas. Key features include a requirement for regulatory expertise in drug/device development and a unique Partnering Principal Investigator option. Review criteria focus on research rationale, strategy, feasibility, and impact, enhancing military health outcomes.

About Father John Foundation GrantIn 1997 Monsignor John P. Hourihan established this perpetual charitable foundation for the purpose of funding care for the homeless and people with disabilities, especially the deaf and hard of hearing. The purpose of the Foundation is to financially assist churches and other non-profit organizations, that do not take more than insubstantial government funding, in administering their programs. Our giving focus is broad and considers programs that are: religious, educational, rehabilitational, social, and/or vocational. A priority is given to the deaf and homeless. All funding is given regardless of nationality, race or religion. The Foundation will continue its dedication to raising and distributing grants to be used by charities devoted to providing care and services to the homeless and disabled.

The Retina Society, Inc.

The Retina Society was founded in 1968 exclusively for educational and scientific purposes concerning the diagnosis, care and treatment of diseases and injuries to the retina. The Retina Society began as an outgrowth of alumni meetings of Retina Associates, a retina practice founded in Boston in 1951 by Charles L. Schepens. Dr. Schepens is credited with establishing retina surgery as a sub-specialty.  

Our mission is to reduce worldwide visual disability and blindness by promoting the education and professional interaction of vitreoretinal specialists, providing optimal care for patients with vitreoretinal diseases, and encouraging, through clinical and basic research, the discovery and development of new means to further patient care.

Retina Society Research Grants

Supporting the advancement of knowledge and education throughout the global retina community, The Retina Society established a research and education grant program in 2020 to fund annual innovative research grants by Retina Society members in good standing. In 2022, we entered into a partnership with the International Retina Research Foundation to fund three $50,000 grants.

• The applications should fall in one of two categories:
  • basic science/translational research
  • clinical research

Proposed research should attempt to advance our understanding of vitreoretinal physiology or pathophysiology or pursue avenues for potential therapies or therapeutic innovation.

The Retina Society, Inc.

The Retina Society was founded in 1968 exclusively for educational and scientific purposes concerning the diagnosis, care and treatment of diseases and injuries to the retina. The Retina Society began as an outgrowth of alumni meetings of Retina Associates, a retina practice founded in Boston in 1951 by Charles L. Schepens. Dr. Schepens is credited with establishing retina surgery as a sub-specialty.  

Our mission is to reduce worldwide visual disability and blindness by promoting the education and professional interaction of vitreoretinal specialists, providing optimal care for patients with vitreoretinal diseases, and encouraging, through clinical and basic research, the discovery and development of new means to further patient care.

Retina Society Underrepresented in Medicine (RESOURCE) Mentoring Program

The Retina Society Underrepresented in Medicine (RESOURCE) Mentoring Program was created to engage and interest ophthalmology residents from underrepresented populations* in research and in pursuing careers in the retina subspecialty through dedicated mentoring exposure. The program will pair ophthalmology residents from underrepresented backgrounds with Retina Society mentors, with the goal of providing the residents with research and career mentorship.

*The American Association of Medical Colleges definition of underrepresented in medicine is: "Underrepresented in medicine means those racial and ethnic populations that are underrepresented in the medical profession relative to their numbers in the general population." We define the following groups as underrepresented: Black (African American or African), Latino/Hispanic, American Indian, Alaska Native, Native Hawaiian or Pacific Islander. We will also be considering applicants from LGBTQIA+ and socioeconomically underprivileged backgrounds.

Mentors will work with their designated mentees on research projects that will be presented at the Retina Society Annual Meeting in 2027 and submitted for publication consideration. Mentors and mentees will be acknowledged at the Retina Society Annual Meeting.

Retina Research Foundation

Across the nation, there were only a handful of voluntary groups with the will and the means to tackle retinal disdorders. Retina Research Foundation, established in 1969, was one of those organizations. By the 1980s, RRF had become a voice for retina research in an effort to reduce the incidence of retinal disease, which was fast becoming the leading cause of blindness in developing countries.

Undaunted, the Foundation steadily raised funds each year for vision scientists who were nationally recognized for their work in retina research. Government funding for eye research increased dramatically, and the field of retina research matured. As this body of knowledge grew, RRF programs were expanded to include major awards that recognize established retina scientists and contribute to their ongoing research. The Foundation also developed scientific exchange programs to disseminate knowledge of the dramatic advances that were being made in the laboratory.

RRF Pilot Study Grants

The mission of the Retina Research Foundation is to reduce retinal blindness worldwide by funding programs in research and education. As a public charity, RRF raises funds from the private sector and the investment of its endowment funds.

RRF is currently welcoming pilot study grant applications for the 2027 grant period. Each grant application must be signed by the principal investigator and either their Department Chair or Dean of Research.

The Fredric Rosemore Low Vision Educational Grant, awarded by the American Academy of Optometry Foundation since 2012, aims to foster excellence in low vision education at North American optometry institutions. Each grant provides $1,000 to support various needs such as personnel, equipment, or care, aligning with the mission of the AAOF. Eligible applicants include members of the AAO, whether they are students, candidates, or Fellows.

The NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional) aims to foster innovative research career development for clinically trained vision scientists. This funding opportunity encourages institutions to develop programs that prepare scholars for independent research careers, particularly in minimal risk clinical trials. Emphasis is placed on recruiting underrepresented groups in research, ensuring a diverse pool of clinician investigators engaged in vision research.

The Alma Gibbs Donchian Foundation provides grants primarily to support institutions in Vermont, focusing on issues such as elderly welfare, educational assistance for learning disabilities, and community preservation. Emphasizing partnerships and innovative program models, the Foundation prefers applicants with a strong financial management background. Grants typically range from a few thousand dollars to $20,000, with larger amounts considered for significant impact projects. Eligibility is limited to tax-exempt organizations.

The Catalyst Award for Innovative Research Approaches for Age-Related Macular Degeneration (AMD) provides $300,000 in funding to U.S. researchers exploring novel treatments and understanding of AMD. This initiative, co-funded by partners such as the American Macular Degeneration Foundation, encourages high-risk, high-gain research that could lead to significant advancements in AMD therapies. Each award is designed to support innovative projects that are not yet in clinical trials, fostering groundbreaking work in vision science.

The Disney Award for Amblyopia Research, funded by Research To Prevent Blindness Inc, aims to advance research in amblyopia diagnosis and treatment. Grants of up to $150,000 will support exceptional ophthalmic scientists conducting significant research. Eligible nominees include U.S. researchers from various academic ranks, with a focus on independent research. Proposals should highlight relevance to amblyopia's pathophysiology, diagnosis, or treatment, with awards available until Spring 2025.

The Medical Student Eye Research Fellowship offers a unique opportunity for medical students to dedicate a year to research in ophthalmology, focusing on any vision-related topic. Supported by Research to Prevent Blindness and other partners, the fellowship includes a $30,000 grant and potential additional funding for relocation. Eligible candidates must be U.S. citizens or permanent residents and be nominated by RPB-supported Chairs. The program aims to promote diversity and innovation in vision research.

The Stein Innovation Award supports innovative vision research by providing funding to Department of Ophthalmology faculty and other researchers. With deadlines in January and July, the award encourages projects that advance the understanding of the visual system and related diseases. Eligible candidates must be affiliated with U.S. institutions of higher education, and prior nomination forms are required for application acceptance. This initiative aims to foster groundbreaking research in the field of ophthalmology.

The Heiser Program for Research in Leprosy, established by Dr. Victor G. Heiser, focuses on innovative biomedical research to combat leprosy. Since 1975, it has funded over 200 grants totaling more than $20 million, supporting early-career researchers and significant projects. The program aims to enhance diagnostic tools, improve treatments, and implement effective surveillance strategies. With a dedicated Scientific Advisory Committee, it ensures rigorous proposal reviews and fosters collaboration among grantees, ultimately advancing leprosy elimination efforts.

The Genentech Career Development Award for Underrepresented Minority Emerging Vision Scientists, offered by ARVO, supports early-career underrepresented minority investigators in establishing independent vision research programs. This two-year grant provides $100,000 for research and personnel costs, aiming to foster innovative project ideas and promising preliminary results. Successful applicants will receive strong mentorship within the eye and vision research community, facilitating career advancement and the potential for impactful scientific publications.

Biogen Corporate Sponsorships provide funding to support congresses, events, and initiatives in exchange for tangible benefits such as marketing opportunities and recognition. Applications are reviewed on a rolling basis, and requests must be submitted 50 days in advance. Biogen considers various disease areas for sponsorship, including Alzheimer’s and Multiple Sclerosis. Approval depends on funding availability, alignment with interests, and event details, ensuring transparency for all potential sponsors.

The Voelcker Fund Grant supports 501(c)(3) non-profit organizations conducting medical research, focusing on diseases like cancer and heart disease. It provides restricted grants, emphasizing research that seeks cures in the Greater Bexar County area, particularly for conditions affecting the retina. The fund prioritizes organizations in San Antonio and offers various funding structures, including seed and matching grants, while ensuring compliance with non-discrimination policies.

The NEI Postbaccalaureate Opportunities in Vision Science (POVS) Research Education Program aims to enhance the training of a diverse workforce in biomedical research. This NIH-funded initiative focuses on providing intensive, hands-on research experiences for recent college graduates from various backgrounds, preparing them for doctoral programs in biomedical fields. The program encourages participation from individuals without prior research opportunities in vision sciences, fostering a nationally recruited cohort for substantial impact in the field.

The Academic Research Enhancement Award (AREA) supports small-scale research grants for institutions with limited NIH funding, emphasizing biomedical research experiences for undergraduates. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million in NIH support over the past seven years. This initiative aims to enhance the research environment at these institutions, fostering student involvement in research activities.

The NEI Small Business Innovation Research (SBIR) Cooperative Agreement aims to support small businesses in conducting early-stage clinical trials that pose greater than minimal risk. The program focuses on Phase I and II trials designed to evaluate interventions for vision disorders. Key deadlines for applications include January 30, 2024, and May 24, 2024, among others. Applicants are encouraged to consult with NEI staff prior to submission to ensure alignment with funding opportunities.